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Abstract: 1 
Objectives: 2 
To estimate the cumulative effective dose of radiation (E) and additional lifetime 3 
attributable risk (LAR) of cancer from ionizing radiation in children with 4 
osteogenesis imperfecta (OI), who require frequent imaging for fractures and 5 
bone densitometry (DXA) surveillance. Also, to evaluate the pattern of long bone 6 
fractures.  7 
 8 
Methods: 9 
We reviewed all imaging (x-rays, DXA and computed tomography [CT]) 10 
conducted in a cohort of children with OI with a minimum observation period of 11 
5 years. For each image, E was estimated using age-dependent local data, and 12 
LAR of cancer was extrapolated. LAR and fracture data were compared among 13 
children with mild, moderate and severe OI. LAR was allocated to cancer risk 14 
categories, and the moderate risk group (1 in 1,000 to 1 in 100) was evaluated 15 
further.  16 
 17 
Results:  18 
Results from 106 children with OI (50% females, 5747 images) are presented, 19 
with a median (range) observation period of 11.7 (5.2-15.6) years. CT accounted 20 
for 0.8% of total imaging procedures but contributed to 66% of total E. The 21 
overall LAR of cancer was minimal, averaging an additional 8.8 cases per 22 
100,000 exposed patients (0.8-403). LAR was significantly lower in children with 23 
mild OI compared to those with moderate (p=0.006) and severe OI (p=0.001). All 24 
patients with a moderate LAR of cancer (n=8) had undergone CT scans and 88% 25 
 4 
had scoliosis or vertebral fractures. The cohort experienced 412 long bone 1 
fractures, with the most common site being the femur (26.5%).  OI severity 2 
correlated positively with long bone fracture rates (p<0.001).  3 
 4 
Conclusions: 5 
When compared to baseline LAR of cancer (50%) the additional cancer risk from 6 
ionizing radiation imaging in our paediatric OI cohort was small (0.0088%). To 7 
reduce additional cancer risk, we recommend replacing spinal x-rays with 8 
vertebral fracture assessments on DXA and exercising caution with CT imaging. 9 
 10 
 11 
Keywords:  12 
Osteogenesis imperfecta, cumulative radiation exposure, lifetime cancer risk, x-13 
rays, fractures. 14 
 15 
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1. Introduction: 1 
 2 
Osteogenesis imperfecta (OI) is a heterogeneous, inheritable bone fragility 3 
disorder, caused by defects in the production or processing of type I collagen. 4 
Affected children experience low impact fractures, poor fracture healing, 5 
decreased linear bone growth and bony deformities [1].  6 
Fractures in general are common in children, with peak incidence rates at 14 7 
years in boys and 11 years in girls [2]. In a cohort of Danish subjects with OI, the 8 
highest fracture rate was also in childhood (0-19 years of age) with peak 9 
incidence rates between 0-5 years and 10-15 years in boys, and 0-10 years in 10 
girls [3]. Fracture frequency is also influenced by OI phenotype; children with 11 
mild OI have an annual incidence rate of less than 1, moderate OI of 3, and severe 12 
OI of greater than 3 fractures [4].  13 
Given their high fracture risk, children with OI require multiple x-rays for 14 
investigation of suspected fractures, as well as serial follow-up x-rays to assess 15 
fracture healing. They also require regular monitoring of bone densitometry and 16 
radiological assessment for vertebral fractures and spinal deformities, which 17 
further adds to their cumulative radiation exposure [5]. The effective dose of 18 
radiation (E) from multiple radiological examinations results in an additional 19 
lifetime cancer risk. For each unit (Sievert) of radiation exposure, the risk of 20 
cancer is highest for girls aged 0 to 9 years [5]. Cancer risk is also dependent on 21 
the body site exposed to the radiation [6]. Cancer following exposure to high-22 
dose radiation is usually seen within 3-5 years for leukaemia and beyond 10-15 23 
years for solid tumors [7]. Repetitive radiation exposure at an early age may 24 
result in a significant lifetime cancer risk in children with OI.  In contrast to other 25 
 6 
childhood chronic illnesses [8-13], no studies to date have assessed cancer risk 1 
from radiation exposure in children with OI.  2 
 3 
1.1 Aims:  4 
1. To estimate cumulative E and additional lifetime attributable risk (LAR) of 5 
cancer from diagnostic and surveillance imaging performed on a cohort of 6 
children with OI. To compare E and LAR across age groups, OI phenotypes, 7 
sex and with respect to family history of OI.  8 
2. To compare the number of long bone fractures by site, age and OI phenotype. 9 
3. To evaluate if family history of OI or OI phenotype affects the proportion of 10 
fracture-positive images in children presenting with an injury.   11 
 12 
2. Methods: 13 
 14 
2.1 Study design and patient selection: 15 
This is a retrospective observational cohort study. Due to the nature of the study, 16 
ethics approval was not required. The cohort included all patients managed at 17 
Birmingham Children’s Hospital, UK, with a clinical diagnosis of OI. Patients were 18 
selected from the hospital OI database. To ensure the follow up period was 19 
representative we chose a minimum observation period of 5 years.  20 
 21 
2.2 Patient-specific data collection: 22 
The following demographic data was collected for each patient; sex, age, type of 23 
OI based on clinical phenotype, genetic confirmation of OI (if available) and 24 
family history of OI in a first-degree relative. Each patient was classified as either 25 
 7 
mild, moderate or severe phenotype based on the updated Sillence classification 1 
[4]. 2 
Each patient’s imaging procedures that involved the use of ionizing radiation (x-3 
ray, dual-energy x-ray absorptiometry (DXA) and computed tomography (CT)) 4 
were reviewed on the institution’s ‘Picture Archiving and Communication 5 
System’ (PACS) from birth or 2003 (installation of the PACS system) until 6 
December 2016.  Therefore, the observation period differed in the cohort, 7 
ranging between 5 -15 years. For each imaging procedure, the following was 8 
recorded; age of patient at scan, type of scan (x-ray, DXA or CT), region of body 9 
scanned, reason for scan, presence of a new fracture (as described in 10 
radiologist’s report), site of fracture and estimated E in milliSievert (mSv).  11 
 12 
2.3 Fracture-positive rate:  13 
‘Reason for the scan’ was documented in five categories; investigation for injury 14 
with a fracture reported (fracture-positive) or without (fracture-negative), 15 
ongoing monitoring of fracture healing, surveillance imaging (e.g. for scoliosis), 16 
and no reason identified.  We then calculated the rate of fracture-positive x-rays 17 
relative to all x-rays taken for investigation of injury. 18 
 19 
2.4 Estimation of effective radiation dose: 20 
Age-specific E for each image type was estimated with data collected from our 21 
institution using the PCXMC x-ray dosimetry program (A Monte Carlo Program 22 
for Calculating Patient Doses in Medical X-ray Examinations, Version 2.0, 2008, 23 
STUK, Finland) or the ImPACT CT Dosimetry program (CT patient Dosimetry 24 
Calculator, Version 1.0.4, 2011, ImPACT, London, UK). If this data was not 25 
 8 
available then standard data (i.e.: not age-specific) was used, from HPA-CRCE-1 
012 Report Appendix A (E103) [14]. For DXA scans, E was determined with 2 
reference to the manufacturer’s specifications (Lunar enCORE iDXA, GE Medical 3 
Systems Lunar, Madison, USA).  4 
 5 
2.5 Estimation of lifetime attributable risk of cancer: 6 
For each patient cumulative E was calculated by summing E, in two exposure age 7 
groups (0-9 and 10-19 years) and five different body sites (head, neck, chest, 8 
abdomen and pelvis). To calculate LAR, cumulative E was multiplied by an age, 9 
body site and sex-specific risk coefficients as per HPA-CRCE-028 Report, Table 10 
29, page 56 [6]. These values were then summed to give the total LAR for that 11 
individual’s period of observation. Each patient’s LAR was then extrapolated to 12 
an observation period of 18 years to allow results to be comparable. LAR data 13 
was then allocated to a cancer risk category as described in HPA-CRCE-028 14 
Report, page 49-50 [6]. 15 
 16 
2.6 Statistical analysis:  17 
The above calculations used Microsoft Office Excel 2010 (Microsoft Corporation, 18 
Redmond, WA) and data was statistically analyzed by a qualified statistician 19 
using SPSS (SPSS Statistics for Windows, Version 22.0, Armonk, NY:IBM Corp). 20 
To compare LAR in male and female patients a Mann-Whitney test was used. 21 
Kruskal-Wallis and Dunn’s tests were used to compare the three OI phenotypes 22 
with respect to LAR, cumulative E per year, number of fracture-positive x-rays 23 
per year and the fracture-positive rate. To assess the impact of age on radiation 24 
exposure each patient’s cumulative E data was split into five age groups: 0-2, 2-5, 25 
 9 
5-9, 9-14 and 14-19 years, and a Jonckheere-Terpstra test was used to compare 1 
E in each group. Impact of family history on cumulative E, LAR and fracture-2 
positive rate was assessed using a Mann-Whitney test. A Jonckheere-Terpstra 3 
test was used to compare long bone fracture rate between OI phenotypes and 4 
Fisher’s exact tests to evaluate fracture site and age groups.  5 
 6 
3. Results: 7 
 8 
A total of 197 children with OI were identified from the hospital database. Forty-9 
five children were under five years of age and 46 were managed jointly with 10 
peripheral hospitals (all images of whom were not available for review) and 11 
hence they were excluded. The final study cohort therefore comprised 106 12 
patients, 53 males and 53 females.  Phenotypically, 74 patients were considered 13 
to have mild OI, 22 moderate and 10 severe. Further details about the cohort are 14 
summarized in Table 1. 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 10 
Table 1: Characteristics of the study cohort: OI phenotype, sex, family history of 1 
OI, observation period and age [median (range)]. 2 
OI 
phenotype 
Male Female Family 
history 
Observation 
period (years) 
Age at inclusion 
(years) 
Mild 
(n=74) 
39 35 51 (69%) 11.2 (5.2-14.2) 2.47 (0.00-15.10) 
Moderate 
(n=22) 
10 12 13 (59%) 14.0 (5.7-15.4) 2.95 (0.01-11.20) 
Severe 
(n=10) 
4 6 6 (60%) 11.0 (6.5-15.6) 0.01 (0.00-2.23) 
 3 
The types of OI included in this study were Type I (n=72), Type III (n=6), Type IV 4 
(n=17), Type V (n=2), Type IX (n=3), Type XI (n=1), Type XIII (n=2) and Type XIV 5 
(n=3).  6 
 7 
Over the median (range) observation period of 11.7 years (5.2 – 15.6) a total of 8 
5747 images using ionizing radiation were performed, averaging 3.8 images per 9 
patient per year. Of the total imaging procedures, 91.6% were x-rays, 7.6% DXA, 10 
and 0.8% were CT. Across the cohort, CT contributed to 66% of cumulative E, 11 
while x-ray and DXA were 31% and 3% respectively (Figure 1).  12 
 13 
 11 
 1 
Figure 1: Contribution of each imaging modality to total number of imaging 2 
procedures and cumulative effective dose of radiation (E).  3 
 4 
3.1 Cumulative effective radiation doses:  5 
The median cumulative E across the cohort was 0.45 mSv (0.02 - 14.99), or 0.04 6 
mSv per year. Cumulative E per year was lower in children with mild OI 7 
compared to moderate (p = 0.006) and severe OI (p = 0.001), but was not 8 
different between moderate and severe phenotypes (p = 0.715) (Table 2). 9 
When examining cumulative E by age group there was a significant trend for 10 
increased E with age (p ≤ 0.001). The 9-14 year age group had the highest E 11 
mean at 0.169 mSv/year (SD 0.33) [range 0-1.6] and the 2-5 year age group had 12 
the lowest E at 0.089 mSv/year (SD 0.29) [range 0-1.94]. 13 
 14 
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Table 2: Number of images, cumulative E and LAR (predicted number of cancer 1 
cases per 100,000 exposed) for each OI phenotype [median (IQR 25-75)]. 2 
OI 
phenotype 
Total 
number 
of images 
Images 
per year 
Total 
cumulative 
E (mSv) 
Cumulative E 
per year 
(mSv/year) 
LAR of cancer 
Mild 33  
(17-47) 
3.1 
(1.9–5.0) 
0.323  
(0.123-
1.061) 
0.029 *

 
(0.012 - 0.086) 
5.5 *

 
(2.3-14.3) 
Moderate 57  
(33-91) 
5.4  
(2.7–8.2) 
0.887  
(0.479 – 
2.382) 
0.069  
(0.040 – 
0.228) 
13  
(8.3-55.7) 
Severe 138  
(76-192) 
9.8  
(5.9–22.9) 
1.821  
(0.834 – 
8.127) 
0.137  
(0.059 – 
0.685) 
27  
(10.8-118.3) 
* p0.01 when compared to moderate 3 

p=0.001 when compared to severe 4 
 5 
3.2 Predicted LAR of cancer: 6 
The median additional LAR of cancer across the whole cohort was 8.8 cases per 7 
100,000 exposed patients (0.0088%). LAR did not differ between sexes 8 
(p=0.997). However, LAR was significantly lower in mild OI compared to 9 
                                                 
 
 
 
 13 
moderate (p=0.01) and severe OI (p=0.001), but did not differ between moderate 1 
and severe OI (p=0.644) (Table 2, Figure 2).  2 
 3 
 4 
* p ≤ 0.01 when compared to moderate 5 

p = 0.001 when compared to severe  6 
Figure 2: Number of predicted cases of cancer per 100,000 exposed patients, 7 
secondary to radiation from medical imaging (median, IQR 25 & 75 and range).  8 
 9 
Figure 3 shows LAR of cancer by risk category, noting that half of the cohort falls 10 
into ‘very low risk’ (1 case in 100,000 to 1 in 10,000). Patients with severe OI are 11 
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 14 
either categorized as ‘low’ (1 in 10,000 to 1 in 1,000) or ‘moderate’ risk (1 in 1 
1,000 to 1 in 100).  2 
 3 
 4 
Figure 3: Lifetime attributable risk (LAR) of cancer by risk category and OI 5 
phenotype 6 
 7 
Further characterisation of the moderate risk patients (Table 4), demonstrates 8 
the contribution of CT scans and repeated spinal x-rays to overall LAR.  Patients 9 
in the moderate risk group had more spinal x-rays (median 0.904/yr) when 10 
compared to patients in the low and very low risk groups (0.503/yr and 11 
0.155/yr respectively).  12 
 13 
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Table 4: Characteristics of patients in the moderate risk of cancer category (1 in 1 
1,000 to 1 in 100). 2 
Patient  OI 
phenotype 
Number 
of spinal 
x-rays 
Number 
of CT 
scans 
Vertebral 
fractures/ 
scoliosis  
Observation 
period 
(years) 
LAR of 
cancer 
1 Mild 17 1 Yes 8 1 in 925 
2 Mild 15 6 Yes 12 1 in 662 
3 Mild 0 3 No 6 1 in 495 
4 Mild 8 1 No* 14 1 in 841 
5 Moderate 13 2 Yes 7 1 in 478 
6 Moderate 11 3 Yes 7 1 in 248 
7 Severe 9** 2 Yes 10 1 in 307 
8 Severe 21 2 Yes 8 1 in 343 
* Note: Patient 4 has a history of spondylolisthesis 3 
**Note: Patient 7 had 16 pelvic x-rays (due to bilateral femoral neck fractures)  4 
 5 
3.3 Fracture patterns:  6 
The cohort experienced 412 long bone fractures; the most common bone 7 
fractured was the femur (26.5%, p <0.001). OI severity correlated positively with 8 
long bone fracture rates (p<0.001), with the median annual fracture rate (range) 9 
for mild OI at 0.20 (0-1.00), moderate 0.28 (0-2.43) and severe 0.80 (0-3.22). 10 
Categorized by age group, the most common long bone fractured was the femur 11 
(45% of patients) in 0-2 year olds, tibia (30%) in 2-5, radius (23%) in 5-9 and 12 
 16 
femur in both 9-14 (31%) and 14-19 year olds (46%). 73% of the cohort had 1 
radiographic evidence of at least one vertebral fracture.   2 
 3 
3.4 Fracture-positive rate: 4 
The rate of fracture-positive imaging was 60%, i.e. for every 10 images taken for 5 
investigation of an injury 6 would identify a fracture. Both the rate of fracture-6 
positive imaging and the number of fracture-positive images per year were not 7 
different between OI phenotypes (p=0.654 and 0.051, respectively). This may be 8 
due to the small number of patients with severe OI, as clinically a difference 9 
would be expected.  10 
 11 
3.5 Family history of OI:  12 
There was no significant difference in cumulative E or LAR (p = 0.371 and 0.254 13 
respectively) between patients with and without an affected first-degree family 14 
member. A sub-analysis of these two groups by OI phenotype also showed no 15 
significant difference in cumulative E (mild p=0.678, moderate p=0.117 and 16 
severe p=0.136). Of note, a family history of OI did not influence the rate of 17 
fracture-positive imaging (p=0.764).  18 
 19 
4. Discussion: 20 
 21 
This is the first study to assess cumulative E and LAR of cancer in a cohort of 22 
paediatric patients with OI. Here we demonstrate that the typical OI patient in 23 
our cohort underwent an average of 3.8 imaging procedures per year using 24 
ionizing radiation.  As expected, the number of imaging procedures and LAR 25 
 17 
correlated with OI severity. Radiation awareness is important, since each mSv of 1 
radiation encountered during childhood has a 2-5 fold increase in the risk of 2 
developing cancer when compared to the same dose of radiation received during 3 
adulthood [6].  However, since x-ray was the most common imaging modality in 4 
our cohort, the cumulative E and LAR appears less than for other chronic 5 
childhood illnesses where high-radiation procedures are more common (such as 6 
congenital heart disease[8]).  7 
 8 
There are only a few other studies that used similar methods of calculating 9 
cancer risk, the most relevant examines a cohort of patients with complex 10 
congenital heart disease [8]. Their median cumulative E (2.7mSv) and estimated 11 
LAR (65 cases per 100,000 exposed) was much higher than in our cohort. 12 
However, cardiac catheterization contributed to 60% of the total E. Similar to our 13 
cohort, the severity of the disease correlated with the LAR of cancer (1677 cases 14 
per 100,000 exposed in the cardiac transplant group). The difference in 15 
cumulative E and LAR between the moderate and severe OI phenotypes did not 16 
reach significance. We hypothesize this was due to the small group of patients 17 
with severe OI (n=10), equally it could also be explained by the younger age at 18 
study inclusion and hence the observation period not covering the whole of 19 
adolescence (9-14 years) when cumulative E was found to be at it’s highest.  20 
 21 
In the moderate risk of cancer group, all patients had at least one CT scan and 22 
most (88%) required repeated spinal x-rays. Although CT scans were not 23 
performed frequently (0.8% of imaging events) they contributed to a large 24 
portion (66%) of the total exposure in our cohort. This highlights the importance 25 
 18 
of radiation protection principles (justification, optimization, dose limits) and 1 
should encourage clinicians to consider alternatives to CT where possible [15].    2 
 3 
Yearly cumulative E peaked at 9-14 years of age, which is consistent with the 4 
period of highest fracture incidence in the general childhood population in the 5 
UK [2]. As expected long bone fracture rates showed a significant upward trend 6 
with increasing severity of OI. The most common fracture sites were femur, tibia 7 
and radius which is similar to other published data [3,16].   8 
 9 
We had speculated that a positive family of OI, which assumes a better 10 
understanding of the condition and less parental anxiety, would lead to fewer 11 
presentations with minor injuries and hence higher rates of fracture-positive 12 
imaging. However, this hypothesis was not supported by our data. Interestingly, 13 
patients with severe OI also had no change in their fracture-positive rate, 14 
although this may again be secondary to the small sample size (n=10).  15 
 16 
The strengths of this study include a large rare-disease cohort, a long period of 17 
observation (median 11.7 years) and the method of calculating cumulative E by 18 
reviewing each individual image. Radiation exposure from routine examinations 19 
is not standardized in paediatrics, however we used institution-specific age-20 
dependent E data whenever available, and this added to the accuracy of 21 
calculating cumulative E. We also used published age, body site and sex-specific 22 
risk coefficients to calculate LAR, as each of these factors impact lifetime cancer 23 
risk. 24 
 19 
A limitation of this study is the small sample size in the severe OI phenotype 1 
group (n=10). We did not have the required information to calculate patient-2 
specific E doses, although by using age-dependent E this provided a good 3 
estimation. We recognize that to compare LAR, data was extrapolated to 18 4 
years, and this may have led to a slight overestimation, most notably in the 5 
patients with short observation periods and high cumulative E doses (such as 6 
Patient 3, Table 4). However, the overall trend of increasing LAR with OI severity 7 
mirrors the increase seen in cumulative E, which is un-extrapolated data.  8 
 9 
4.1 Conclusions: 10 
In conclusion, given that the lifetime risk of developing cancer in the UK is 50% 11 
[17], the predicted additional risk of cancer from medical imaging in our cohort 12 
was minimal. However we identified a high-risk group (those with vertebral 13 
fractures, scoliosis or severe OI) that would benefit from a reduction in radiation 14 
exposure. Replacing spinal x-rays with Vertebral Fracture Assessment (VFA) 15 
using DXA can considerably lower radiation exposure but give similar clinical 16 
information [18]. We suggest using VFA as a screening tool for vertebral 17 
fractures and for routine surveillance of vertebral height (such as vertebral 18 
remodeling while on bisphosphonate therapy) [19]. Considering alternative 19 
forms of imaging, such as MRI, DXA or EOS imaging, in an attempt to avoid CT is 20 
also imperative [20].  Improvements in the medical management of patients with 21 
OI have resulted in a longer life expectancy, therefore the cumulative E from 22 
medical imaging we report becomes more relevant. 23 
  24 
 20 
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